GEN DE WITTELAAN L11 A3, 2800 MECHELEN, C9
To Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Acquisition of Own Shares
Issues Press Release on September 1, 2026
Receives Transparency Notification
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
No filings found
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Automatic Shelf Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Submission Upload
Correspondence